0000899243-19-002657.txt : 20190205 0000899243-19-002657.hdr.sgml : 20190205 20190205173632 ACCESSION NUMBER: 0000899243-19-002657 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190204 FILED AS OF DATE: 20190205 DATE AS OF CHANGE: 20190205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Elam Nevan C CENTRAL INDEX KEY: 0001314773 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32157 FILM NUMBER: 19569052 MAIL ADDRESS: STREET 1: C/O NEKTAR THERAPEUTICS STREET 2: 150 INDUSTRIAL ROAD CITY: SAN CARLOS STATE: CA ZIP: 94070 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Savara Inc CENTRAL INDEX KEY: 0001160308 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841318182 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 S. CAPITAL OF TEXAS HIGHWAY STREET 2: SUITE 150 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: 512-614-1848 MAIL ADDRESS: STREET 1: 900 S. CAPITAL OF TEXAS HIGHWAY STREET 2: SUITE 150 CITY: AUSTIN STATE: TX ZIP: 78746 FORMER COMPANY: FORMER CONFORMED NAME: Mast Therapeutics, Inc. DATE OF NAME CHANGE: 20130312 FORMER COMPANY: FORMER CONFORMED NAME: ADVENTRX PHARMACEUTICALS INC DATE OF NAME CHANGE: 20030613 FORMER COMPANY: FORMER CONFORMED NAME: BIOKEYS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20010928 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-04 0 0001160308 Savara Inc SVRA 0001314773 Elam Nevan C 6836 BEE CAVE ROAD, BUILDING III SUITE 200 AUSTIN TX 78746 1 0 0 0 Common Stock 2019-02-04 4 M 0 21682 0.19 A 21682 D Stock Option (Right to Buy) 0.19 2019-02-04 4 M 0 21682 0.00 D 2019-02-20 Common Stock 21682 0 D The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on May 20, 2009. 5,420 shares subject to the option became vested and exercisable on October 22, 2010. /s/ David Lowrance, David Lowrance as attorney-in-fact for Nevan C. Elam 2019-02-05